Among fit patients with acute myeloid leukemia, the combination of azacitidine plus Venclexta (venetoclax) was associated ...

Among patients experiencing chronic graft-versus-host disease (cGVHD), the transition of treatment with Niktimvo (axatilimab) ...

OS for Black patients was 57.8 months in those with a favorable ELN cytogenic RS, 14.2 months for those with intermediate RS ...

Real-time text check-ins helped physicians identify issues sooner and support quality of life for patients with myeloma at ...

Among older patients with newly diagnosed diffuse large B-cell lymphoma (DLBCL), treatment with fixed-duration Epkinly (epcoritamab-bysp) plus dose-attenuated Rituxan (rituximab) plus cyclophosphamide ...

Among patients who were newly diagnosed with multiple myeloma, Kyprolis (carfilzomib) plus Revlimid (lenalidomide) and dexamethasone (KRd) was associated with improvements in progression-free survival ...

Elrexfio showed higher response rates but shorter PFS compared to Tecvayli in real-world settings for relapsed/refractory ...

One of biggest stories or developments in acute myeloid leukemia or AML is the wider adoption and use of the regimen of ...

From left: Oya Gilbert, Bill Potts, Dr. Faseeh Khaja's nominator, Mayra, and Joe McDonough at the first annual Blood Cancer ...

Nearly 30% of families with children undergoing ALL treatment face catastrophic financial toxicity, including household ...

Emotional readiness often lags behind intellectual awareness, leaving individuals unprepared for a cancer diagnosis. Support ...

The narrative challenges the idea that extended survival equates to sufficient time, emphasizing the profound loss of a young ...